Sandoz

125 articles with Sandoz

• Amgen, Sandoz, Inc. Biosimilar War Could Provide Playbook, Says Analyst

  10/31/2014

• Apricus Biosciences Announces The Launch Of Its Topical Treatment For Erectile Dysfunction Vitaros® In Sweden By Sandoz, Inc.

  8/4/2014

• Anacor Pharmaceuticals, Inc. Inks Exclusive Deal With Sandoz, Inc. For Kerydin; Anacor To Receive Upfront $40 Million

  7/22/2014

• Sandoz, Inc. Stays In New Jersey, Moves To Former Home Of Novo Nordisk A/S

  7/10/2014

• Acura Pharmaceuticals, Inc. Announces Settlement Of Patent Litigation With Sandoz, Inc.

  5/22/2014

• Novartis AG Names New Heads Of Alcon, Inc., Sandoz, Inc. Units

  4/9/2014

• InSite Vision Announces Court Judgment Upholding All AzaSite® Patents in Patent Infringement Lawsuit Against Sandoz, Inc.

  10/7/2013

• AVANIR Pharmaceuticals Announces Settlement of NUEDEXTA Patent Litigation With Sandoz, Inc.

  8/14/2013

• Lupin Ltd. Sets up R&D in U.S., Ropes in Teva Pharmaceutical Industries Limited, Sandoz, Inc. Executives

  8/12/2013

• Sandoz, Inc. Pulls One Lot of Birth Control Pills Over Placebo Issue

  7/8/2013

• Actavis and Kissei Pharmaceutical Co., Ltd. File Lawsuits Against Sandoz, Inc. and Hetero for Infringement of Rapaflo&#0174 Patent

  6/19/2013

• Sandoz, Inc. Recalls Two Lots of Injectable Methotrexate

  5/23/2013

• Amgen, Hospira, Inc. and Sandoz, Inc. Named Among Top Pharmaceutical Companies With Greatest Biosimilar Drug Potential in United States

  5/14/2013

• Amid Reorganization, Sandoz, Inc. Eliminates 100 Jobs

  12/19/2012

• Sandoz, Inc. Closes Med Plant; Cuts 150 Jobs

  12/4/2012

• Sandoz, Inc. Shuts Unit Near Mumbai; 50 Jobs Gone

  8/20/2012

• Sandoz, Inc. Enters Local Cameroon Production Partnership to Increase Access to Quality Medicines in Sub-Saharan Africa

  4/24/2012

• United Therapeutics Corporation Files Lawsuit Against Sandoz, Inc. for Infringement of Remodulin Patents

  3/15/2012

• Drug Shortage Feared as Novartis AG's Sandoz, Inc. Halts Production

  2/21/2012

• Sandoz, Inc. Buys German Rights to Apricus Biosciences' Sex Drug for $28 Million

  2/16/2012